Please enter the email address you used to register, then we will send you a link to choose a new password
Beyond Air, Inc.
https://www.accessdata.fda.gov/scripts/opdlisting/oopd/detailedIndex.cfm?cfgridkey=1091925
D. Boral Capital analyst Jason Kolbert maintains Beyond Air (NASDAQ:XAIR) with a Buy and maintains $11 price target.
Beyond Air (NASDAQ:XAIR) affirms FY2026 sales outlook from $12.00 million-$16.00 million to $12.00 million-$16.00 million vs $1...
Beyond Air (NASDAQ:XAIR) reported quarterly losses of $(1.53) per share which missed the analyst consensus estimate of $(0.07) ...
Beyond Air, Inc. (NASDAQ:XAIR) ("Beyond Air" or the "Company"), a commercial stage medical device and biopharma...